位置：成果数据库 > 会议 > 会议详情页
FAK expression: a potential tumor therapy target
  • 所属机构名称：南京大学
  • 会议名称：The 5’th International Forum on Post-genome Technologies, 2007年9月10-11日, 中国苏州
  • 成果类型：会议
  • 相关项目：分子免疫学
同会议论文项目
分子免疫学
期刊论文 33 会议论文 29 著作 1
同项目会议论文
Structural and functional analysis of FADD mutant proteins
Enhancement of the antitumor properties of TRAIL by its targeted delivery to tumor tissue
FAK expression: regulation and therapeutic potential
Polyethylenimie-mediated gene therapy targeting focal adhesion kinase function as melanonoma tumor t
Structural and functional analysis of FADD mutant proteins
Structural and functional analysis of FADD mutant proteins
Triptolide inhibits T cell activation and proliferation via multiple pathways
Polyethylenimie-mediated gene therapy targeting focal adhesion kinase function as melanonoma tumor t
FAK expression: regulation and application potential
FAK Expression： Regulation and Therapeutic Potential
FAK expression: regulation and application potential
Enhancement of the antitumor properties of TRAIL by its targeted delivery to tumor tissue
Structural and functional analysis of FADD mutant proteins
STUDY ON FADD REGULATES THE DEVELOPMENT OF T LINEAGE LYMPHOCYTES
Enhancement of the antitumor properties of TRAIL by its targeted delivery to tumor tissue
PREPARATION AND PRELIMINARY EVALUATION OF 99mTc LABELED HUMAN RECOMBINANT ANNEXIN V
Structural and Functional Analysis of Fadd Mutant Proteins
Bactera as Tumor Therapy Agent
Enhancement of the antitumor properties of TRAIL by its targeted delivery to tumor tissue
FADD protein: structure and function
FAK基因的表达调控及在肿瘤治疗中的应用前景
Enhancement of Anti-Tumor Properties of TRAIL by Targeted Delivery to the Tumor Neovasculature
Tumor-targeting delivery of TRAIL enhances its anti-tumor efficacy
Polyethylenimie-mediated gene therapy targeting focal adhesion kinase function as melanonoma tumor t
Triptolide inhibits T cell activation and proliferation via multiple pathways
雷公藤内酯醇通过多条通路调节T细胞的活化和增殖
FAK: a potential tumor cancer therapy target
靶向性诱导肿瘤细胞凋亡药物研发